Your session is about to expire
← Back to Search
Hippotherapy for Autism Spectrum Disorder
N/A
Waitlist Available
Led By Anastasia Kyvelidou, PhD
Research Sponsored by Creighton University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be younger than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up during week 1, week 3 and week 6 of the treatment sessions
Awards & highlights
Study Summary
This study is evaluating whether hippotherapy may be beneficial for children with autism spectrum disorders.
Eligible Conditions
- Autism Spectrum Disorder
- Autism
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ during week 1, week 3 and week 6 of the treatment sessions
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~during week 1, week 3 and week 6 of the treatment sessions
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Cross Sample Entropy Between the Heart Rate Sensors of the Horse and Rider
Postural Control
Social Responsiveness Scale (SRS)
Secondary outcome measures
Aberrant Behavior Checklist
Correlation Between Horse Temperament and Therapeutic Outcomes
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Children with Autism Spectrum DisordersExperimental Treatment1 Intervention
Children with autism spectrum disorder will receive a 6 week (once per week) hippotherapy protocol. During the hippotherapy session, the researchers will monitor the heart rate variability of the horse and the rider. Both horse and rider will wear an electrode strap around the upper thorax. Heart rate recordings will be started simultaneously at the beginning of the HPOT session. To assess movement coupling between the horse and rider, five tri-axial inertial sensors (OPAL, APDM, Inc, Portland, OR) will be used. The sensors will collect actively synchronized tri-axial accelerometer and gyroscope data. One inertial sensor will be placed dorsal at the rider's pelvis, one frontal at the top of the forehead, and one frontal at the top of the sternum. The sensors on the horse will be fixed on the back of the horse on the spine level between T8 and T10 and on the head.
Group II: Children with typical developmentActive Control1 Intervention
Children with autism spectrum disorder and with typical development will receive a 6 week (once per week) hippotherapy protocol. During the hippotherapy session, the researchers will monitor the heart rate variability of the horse and the rider. Both horse and rider will wear an electrode strap around the upper thorax. Heart rate recordings will be started simultaneously at the beginning of the HPOT session. To assess movement coupling between the horse and rider, five tri-axial inertial sensors (OPAL, APDM, Inc, Portland, OR) will be used. The sensors will collect actively synchronized tri-axial accelerometer and gyroscope data. One inertial sensor will be placed dorsal at the rider's pelvis, one frontal at the top of the forehead, and one frontal at the top of the sternum. The sensors on the horse will be fixed on the back of the horse on the spine level between T8 and T10 and on the head.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Hippotherapy
2006
N/A
~350
Find a Location
Who is running the clinical trial?
Creighton UniversityLead Sponsor
125 Previous Clinical Trials
25,666 Total Patients Enrolled
Anastasia Kyvelidou, PhDPrincipal Investigator - Creighton University
Creighton University
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger